580 related articles for article (PubMed ID: 28718414)
1. Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity.
Wainwright EN; Scaffidi P
Trends Cancer; 2017 May; 3(5):372-386. PubMed ID: 28718414
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Reprogramming and Cellular Plasticity through Histone Exchange and Histone Variant Incorporation.
Gaume X; Torres-Padilla ME
Cold Spring Harb Symp Quant Biol; 2015; 80():165-75. PubMed ID: 26582788
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity.
Skrypek N; Goossens S; De Smedt E; Vandamme N; Berx G
Trends Genet; 2017 Dec; 33(12):943-959. PubMed ID: 28919019
[TBL] [Abstract][Full Text] [Related]
4. Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance.
Das PK; Pillai S; Rakib MA; Khanam JA; Gopalan V; Lam AKY; Islam F
Stem Cell Rev Rep; 2020 Apr; 16(2):397-412. PubMed ID: 31965409
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic reprogramming in cancer.
Suvà ML; Riggi N; Bernstein BE
Science; 2013 Mar; 339(6127):1567-70. PubMed ID: 23539597
[TBL] [Abstract][Full Text] [Related]
6. Cancer epigenetics: from disruption of differentiation programs to the emergence of cancer stem cells.
Scaffidi P; Misteli T
Cold Spring Harb Symp Quant Biol; 2010; 75():251-8. PubMed ID: 21047903
[TBL] [Abstract][Full Text] [Related]
7. 3D chromatin architecture and epigenetic regulation in cancer stem cells.
Feng Y; Liu X; Pauklin S
Protein Cell; 2021 Jun; 12(6):440-454. PubMed ID: 33453053
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer.
Ravindran Menon D; Hammerlindl H; Torrano J; Schaider H; Fujita M
Theranostics; 2020; 10(14):6261-6277. PubMed ID: 32483452
[TBL] [Abstract][Full Text] [Related]
9. Parallels between artificial reprogramming and the biogenesis of cancer stem cells: Involvement of lncRNAs.
Rasmussen TP
Semin Cancer Biol; 2019 Aug; 57():36-44. PubMed ID: 30273656
[TBL] [Abstract][Full Text] [Related]
10. The epigenetic basis of cellular plasticity.
Paksa A; Rajagopal J
Curr Opin Cell Biol; 2017 Dec; 49():116-122. PubMed ID: 29413970
[TBL] [Abstract][Full Text] [Related]
11. Metal carcinogen exposure induces cancer stem cell-like property through epigenetic reprograming: A novel mechanism of metal carcinogenesis.
Wang Z; Yang C
Semin Cancer Biol; 2019 Aug; 57():95-104. PubMed ID: 30641125
[TBL] [Abstract][Full Text] [Related]
12. Metabolic control of cancer cell stemness: Lessons from iPS cells.
Menendez JA
Cell Cycle; 2015; 14(24):3801-11. PubMed ID: 25738999
[TBL] [Abstract][Full Text] [Related]
13. Current status in cancer cell reprogramming and its clinical implications.
Izgi K; Canatan H; Iskender B
J Cancer Res Clin Oncol; 2017 Mar; 143(3):371-383. PubMed ID: 27620745
[TBL] [Abstract][Full Text] [Related]
14. Cancer cell plasticity: Impact on tumor progression and therapy response.
da Silva-Diz V; Lorenzo-Sanz L; Bernat-Peguera A; Lopez-Cerda M; Muñoz P
Semin Cancer Biol; 2018 Dec; 53():48-58. PubMed ID: 30130663
[TBL] [Abstract][Full Text] [Related]
15. Potential application of cell reprogramming techniques for cancer research.
Saito S; Lin YC; Nakamura Y; Eckner R; Wuputra K; Kuo KK; Lin CS; Yokoyama KK
Cell Mol Life Sci; 2019 Jan; 76(1):45-65. PubMed ID: 30283976
[TBL] [Abstract][Full Text] [Related]
16. Induced pluripotent stem cell technology for dissecting the cancer epigenome.
Semi K; Yamada Y
Cancer Sci; 2015 Oct; 106(10):1251-6. PubMed ID: 26224327
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming to developmental plasticity in cancer stem cells.
O'Brien-Ball C; Biddle A
Dev Biol; 2017 Oct; 430(2):266-274. PubMed ID: 28774727
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation: an epigenetic mark of cellular memory.
Kim M; Costello J
Exp Mol Med; 2017 Apr; 49(4):e322. PubMed ID: 28450738
[TBL] [Abstract][Full Text] [Related]
19. Role of epigenetic modulation in cancer stem cell fate.
Deshmukh A; Binju M; Arfuso F; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2017 Sep; 90():9-16. PubMed ID: 28711634
[TBL] [Abstract][Full Text] [Related]
20. Setting and resetting of epigenetic marks in malignant transformation and development.
Richly H; Lange M; Simboeck E; Di Croce L
Bioessays; 2010 Aug; 32(8):669-79. PubMed ID: 20658705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
